SELP Asp603Asn and severe thrombosis in COVID-19 males

Chiara Fallerini1,2, Sergio Daga1,2, Elisa Benetti2

  • 1Medical Genetics Unit, University of Siena, Policlinico Le Scotte, Viale Bracci, 2, 53100, Siena, Italy.

Insights

COVID-19 severity and mortality are linked to blood clots. A specific gene variant in males, particularly those over 50, increases this risk, suggesting targeted P-selectin therapies.

Area of Science:

  • Genetics and Genomics
  • Infectious Diseases
  • Cardiovascular Medicine

Background:

  • Thromboembolism is a major contributor to COVID-19 severity and mortality.
  • The underlying causes of COVID-19-associated thromboembolism remain unclear.
  • This study investigated genetic factors influencing COVID-19 severity in relation to thrombosis.

Discussion:

  • The homozygosity of the SELP gene variant rs6127 (Asp603Asn) is associated with increased COVID-19 severity in males.
  • This association is more pronounced in males over 50, potentially due to testosterone's downregulation of SELP.
  • Combined homozygosity for SELP rs6127 and specific androgen receptor genotypes (poly Q ≥ 23) further elevates D-dimer levels, indicating heightened thrombotic risk.

Key Insights:

  • Identified a significant association between the SELP rs6127 variant and COVID-19 severity in males.
  • Demonstrated an age-dependent effect in males over 50, linked to hormonal regulation.
  • Revealed an interaction between SELP genotype and androgen receptor variants impacting thrombotic markers.

Outlook:

  • Suggests P-selectin targeted therapies, such as antibodies, as potential adjuvant treatments for high-risk male COVID-19 patients.
  • Highlights the need for personalized medicine approaches based on genetic profiling.
  • Further research into the role of sex hormones and genetic variants in COVID-19 pathogenesis is warranted.

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
77
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
82
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
195
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
65
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K